The Week

Celsius Holdings fell 7.03% this week to close at $30.66. The S&P 500 rose 0.09% over the same stretch, leaving the stock about 7.12 percentage points behind the benchmark. The week charted a soft downward path: Monday opened at $32.30 and briefly touched $33.00 before drifting lower across the next four sessions. Friday’s session dropped to a low of $30.49, and the stock finished near the bottom of its range. Weekly amplitude was 7.77%, with most daily closes landing below the prior session.

Key Events

Company-specific news was thin this week, leaving two opposing signals to drive the narrative. On Tuesday, Celsius was mentioned in a sector recap that framed consumer and leisure operators as navigating uneven demand through restructuring. On Wednesday, a sell-side note reiterated a buy rating and kept the $42 price target, citing a stronger energy portfolio and a steady fundamental outlook. By Saturday, Robbins LLP issued an investor alert over a class action lawsuit against Celsius Holdings, adding a fresh legal overhang just before the weekend.

Analyst Ratings

Coverage on Celsius stands at 24 institutions: 12 rate it buy, 6 rate it overweight, and 6 rate it hold, with no sell or underweight ratings. The consensus rating is buy, and the consensus target price of $42.29 sits roughly 37.9% above the week’s close of $30.66. The target range runs from $26.00 at the low end to $64.00 at the high end, reflecting wide dispersion. Within the water and soft drinks industry, Celsius ranks 4th out of 17 names, towards the front of the peer group.

The Week Ahead

Macro data picks up next week. Tuesday brings the US NFIB small business optimism index, with a prior reading of 99.8. Thursday is heavier: initial jobless claims, final demand PPI figures, the 10-year Treasury auction, existing home sales, wholesale sales, and the EIA natural gas storage change. Watch whether PPI and Treasury yields keep climbing, as that would pressure the valuation backdrop for consumer growth stocks. Celsius has no earnings date in the calendar yet, but any further developments on the class action could continue to sway sentiment.

In Short

The week left a clear split. The analyst base stays supportive—18 of 24 institutions rate the stock buy or overweight, and the consensus target price is nearly 38% above spot—yet the shares underperformed the market with a price-to-earnings multiple near 120x and a class action headline arriving late in the week. None of these pieces point to a single read; the next test sits in how the legal story and next week’s macro data weigh on the valuation.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.